Indiana Controlled Substance License Requirements

Indiana controlled substance license requirements start with a Controlled Substance Registration (CSR) issued by the Indiana Board of Pharmacy. To hold one, you need an active Indiana professional license, a $60 application (for individual practitioners) submitted through the Indiana Professional Licensing Agency’s online portal, and, in almost every case, a separate federal DEA registration. Keeping the CSR active means renewing alongside your professional license and meeting ongoing rules on prescription monitoring, records, inventory, security, and reporting.¹

Who Needs a CSR

Indiana law reaches anyone who manufactures, distributes, or dispenses a controlled substance in the state.² That covers physicians and pharmacies, and it also covers researchers, teaching institutions, hospitals, clinics, and wholesale distributors. Individual CSRs are available to physicians, osteopathic physicians, veterinarians, dentists, podiatrists, advanced practice nurses, physician assistants, and optometrists (whose authority is limited to tramadol).¹

One rule catches multi-site practices: Indiana requires a separate registration at each principal place of business or professional practice where controlled substances are manufactured, distributed, or dispensed.² A physician working at two clinics needs two CSRs.

How to Apply and What It Costs

Individual practitioners apply through the Indiana Professional Licensing Agency’s online portal. The fee is $60 by credit or debit card, plus processing charges, and it is nonrefundable. You must show proof of your active Indiana practitioner license and complete a background check.¹

Facility-based (non-practitioner) CSRs run on a different schedule. The initial application costs $100, a limited application $50, and reinstatement $200. These applications require Board review at a regularly scheduled monthly meeting, so expect longer processing times. Hospitals, clinics, wholesale distributors, and research institutions must also submit procedures to be performed, the types and quantities of controlled substances to be stored by schedule, and protocols covering usage monitoring, inventory control, destruction, security, storage, and access.³

Advanced Practice Nurses and Physician Assistants

APNs and PAs have an extra hurdle. Prescriptive authority in Indiana requires a written collaborative practice agreement with a licensed practitioner that spells out how the two will cooperate, coordinate, and consult on patient care, with provisions for timely review of the APN’s prescribing.⁴ Without a current agreement on file, no CSR and no DEA registration.

The requirement carries into renewal. Every renewal of prescriptive authority must include a current, signed, and dated agreement with all the information required for the initial filing.⁴ A lapsed agreement, or one that wasn’t updated after a change in collaborating physician, can put the registration at risk.

The Federal DEA Registration

A state CSR alone doesn’t let you handle controlled substances. Federal law requires a separate DEA registration, and the DEA will not issue one unless the state’s licensing requirements are already satisfied.⁵ Get the Indiana CSR first, then apply to the DEA.

A DEA Certificate of Registration lasts 36 months. Practitioners renew every three years using DEA Form 224a.⁶ The DEA adjusts the fee periodically, so check the current amount on the DEA’s registration page before applying.

Renewal Timing

Unlike many state credentials on a fixed biennial cycle, a practitioner’s CSR expires when the underlying Indiana professional license expires, and the Board renews them together.² Renewal notices go out at least 90 days before expiration, and your primary Indiana practitioner license must be active before you can renew the CSR.¹ Facility CSR renewals cost $100 and expire on the same date as the facility’s primary license.³

Manufacturers and distributors run on a different clock: their registrations renew biennially under the Board’s rules.²

Indiana previously required two hours of continuing education on opioid prescribing and opioid abuse for CSR registration and renewal. That requirement, at IC 35-48-3-3.5, expired on July 1, 2025.¹ Your individual licensing board may still have its own CE rules on pharmacology and prescribing; check them separately.

Ongoing Compliance Obligations

INSPECT Reporting and Queries

Indiana’s prescription drug monitoring program, INSPECT, imposes both submission and query duties. Licensed dispensers, including out-of-state pharmacies licensed to dispense in Indiana, must submit controlled substance prescription data to INSPECT every 24 hours. The only exception is for practitioners dispensing no more than a 72-hour supply of a Schedule II through V substance.⁷

Prescribers must also check INSPECT before prescribing or dispensing opioids or benzodiazepines to a patient. Skipping the query is the kind of oversight that draws disciplinary action even when nothing else is wrong with the prescription.

Records and Inventory

Every registrant must keep records and maintain inventories that meet both federal and Indiana rules. Registered pharmacies must retain controlled substance prescription records for at least two years. Manufacturers, distributors, and researchers must produce records or electronic printouts within five working days of a request by the Indiana Board of Pharmacy.⁸ Records should show the name and quantity of each substance, dates of receipt or distribution, and recipient identifying information.

Federal regulations require a physical inventory of all controlled substance stocks at least every two years, taken on any date within two years of the previous count. Schedule II substances must be counted exactly; Schedules III through V allow a reasonable estimate.⁹ More frequent informal counts help catch discrepancies before they compound.

Security

Indiana requires that controlled substances in Schedules II through V be stored in a securely locked, substantially constructed cabinet. Pharmacies and institutional practitioners have an alternative: dispersing controlled substances throughout non-controlled stock in a way that makes theft or diversion difficult. Institutional ward and floor stock of Schedule II substances and Schedule III narcotics must go in a locked cabinet or device regardless of that dispersal option.¹⁰

Non-practitioner registrants face more specific federal standards. Schedule I and II materials must be stored in a safe, steel cabinet, or vault meeting detailed construction requirements; Schedules III through V allow somewhat less stringent options, including secured buildings or cage enclosures meeting minimum specifications.¹¹ Access should be limited to authorized personnel, and while surveillance and alarms aren’t strictly required for most practitioners, liability insurers often insist on them.

Theft or Loss Reporting

Missing controlled substances trigger two separate obligations. Indiana rules require registrants to notify the Board of Pharmacy in writing of any theft or significant loss upon discovery, whether or not the substances are later recovered or the responsible party is identified.¹²

On the federal side, DEA registrants must notify their local DEA Field Division Office in writing within one business day of discovering a theft or significant loss, then file DEA Form 106 electronically through the DEA’s secure network application within 45 calendar days. Paper forms are no longer accepted.¹³ Missing the one-business-day notification is a compliance failure that draws scrutiny even when the underlying loss turns out to be minor.

Disposal

You cannot simply discard expired or unwanted controlled substances. A registrant may request assistance from the DEA Special Agent in Charge (SAC) by submitting a DEA Form 41 listing what needs to be destroyed; the SAC will then instruct the registrant to transfer the substances to an authorized registrant, deliver them to the nearest DEA office, or destroy them in the presence of a DEA agent or other authorized person.¹⁴

Practitioners who regularly dispose of controlled substances may receive standing authorization from the SAC, provided they keep detailed records and file periodic summary reports. Many practices simply use a registered reverse distributor, which can pick up controlled substances at the registrant’s location or receive them by common carrier.¹⁵ Document each step.

What Non-Compliance Costs

Administrative Sanctions

The Indiana Board of Pharmacy can impose fines, suspensions, probation, censure, letters of reprimand, and permanent license revocation. The statutory cap on fines is $1,000 per violation under IC 25-1-9-9, and it applies to both individual practitioners and institutional license holders. The Board’s own rule sets fines at 50 percent of the statutory maximum when a higher cap exists, and defaults to the $1,000 ceiling when no other maximum is specified.¹⁶ The Board must consider ability to pay when setting a fine, and cannot suspend a license solely because a fine went unpaid due to inability to pay.

Losing the CSR effectively ends the ability to prescribe or dispense controlled substances, so administrative discipline can end a practice on its own.

Criminal Penalties

Prescribing outside legitimate medical practice is a separate crime. Under Indiana law, a practitioner who knowingly prescribes any Schedule I through V controlled substance without a legitimate medical purpose commits a Level 4 felony, escalating to a Level 3 felony if the offense causes a death.¹⁷ Criminal charges and administrative proceedings often run in parallel; a felony conviction typically means loss of both the CSR and the underlying professional license, on top of imprisonment and fines. Even an investigation that produces no charges can trigger separate Board discipline.

1
Indiana Professional Licensing Agency. Controlled Substances Registration Home
2
Indiana General Assembly. Indiana Code Title 35, Article 48, Chapter 3, Section 35-48-3-3 – Registration Requirements
3
Indiana Professional Licensing Agency. Pharmacy Licensing Information
4
Indiana General Assembly. Title 848, Article 5 – Prescriptive Authority for Advanced Practice Nursing
5
Diversion Control Division, DEA. Registration Q&A
6
Drug Enforcement Administration. Practitioner’s Manual
7
Indiana Professional Licensing Agency. INSPECT FAQs
8
Cornell Law Institute. Indiana Administrative Code 856 IAC 2-4-1 – Records and Inventories
9
eCFR. 21 CFR 1304.11 – Inventory Requirements
10
Cornell Law Institute. Indiana Administrative Code 856 IAC 2-3-34 – Physical Security Controls for Practitioners
11
eCFR. 21 CFR Part 1301 – Security Requirements
12
Cornell Law Institute. Indiana Administrative Code 856 IAC 2-3-33 – Additional Security Controls for Nonpractitioners
13
Federal Register. Reporting Theft or Significant Loss of Controlled Substances
14
eCFR. 21 CFR Part 1317, Subpart A – Disposal of Controlled Substances by Registrants
15
eCFR. 21 CFR 1317.15 – Reverse Distributor Registration Requirements and Authorized Activities
16
Indiana General Assembly. Final Rule LSA Document 24-585 – Fees, Fines, and Penalties
17
Indiana General Assembly. Indiana Code Title 35, Article 48, Chapter 4, Section 35-48-4-1.5 – Dealing in a Controlled Substance by a Practitioner